Women with IBD more likely to adhere to biologics during pregnancy

Women with inflammatory bowel disease were more likely to adhere to biologic therapy during pregnancy than other drug classes, according to study results.Amy Metcalfe, PhD, of the department of obstetrics & gynecology at the University of Calgary, and colleagues wrote that many women with IBD often perceive an increased risk for complications during their pregnancy due to their medications. However, these risks are often overestimated.“Due to these misconceptions about IBD medications, women may completely stop taking their medications during pregnancy or take a lower dosage ofRead More

Share on facebook
Share on twitter
Share on linkedin